Prolongation of Both PT and aPTT
Author:
Silver Bernard J.
Publisher
Springer New York
Reference65 articles.
1. Acharya SS, Coughlin A, Dimichele D. North American rare bleeding disorder study group. Rare bleeding disorder registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemia. J Thromb Haemost. 2004;2:248–56.
2. Ang AL, Kuperan P, Ng CH. Acquired factor V inhibitor—a problem-based systematic review. Thromb Haemost. 2009;101:852–9.
3. Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost. 2006;4:2115–29.
4. Bajaj SP, Rapaport SI, Fierer DS, Herbst KD, Schwartz DB. A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood. 1983;61:684–92.
5. Berkner KL, Runge KW. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost. 2004;2:2118–32.